Your session will expire automatically in 0 seconds.
LEADER 00000cam 2200000 i 4500
001 ocn861895337
003 OCoLC
005 20140322030326.0
008 131028s2014 nyua b 001 0deng
010 2013042849
016 7 101618829|2DNLM
019 853310597
020 9781610392525|q(hbk.)
020 1610392523|q(hbk.)
020 |z9781610392532|q(ebk.)
035 (OCoLC)861895337|z(OCoLC)853310597
035 (Sirsi) i9781610392525
040 DNLM/DLC|erda|beng|cDLC|dIG#|dNLM|dGK8|dYDXCP|dUOK|dBTCTA
049 CKEA
050 04 RS431.A64|bM37 2014
060 10 QZ 11.1
082 00 616.99/4061|223
100 1 Marks, Paul A.,|eauthor.
245 10 On the cancer frontier :|bone man, one disease, and a
medical revolution /|cPaul A. Marks and James Sterngold.
250 First edition.
264 1 New York :|bPublicAffairs,|c[2014]
300 xiv, 251 pages :|billustrations ;|c22 cm
336 text|2rdacontent
337 unmediated|2rdamedia
338 volume|2rdacarrier
504 Includes index.
505 0 Cracking medicine's oldest mystery -- Deciphering the
inner workings of the cell -- The first look deep inside
the cancer cell -- Bringing the new sciences to an old
school -- The moon shot -- Teaching cancer cells to die --
The politics of cancer research -- Memorial Sloan-
Kettering finds its agent of change -- Getting aggressive
in the war on cancer -- A perfect cure- for a single
cancer patient -- Changing cancer care from within --
Enlisting a major new ally- the cancer patient -- Breast
cancer gets its own home -- Learning to love acid -- The
payoff -- Cancer screening as a way of life -- The next
leap.
520 "Paul Marks M.D., President Emeritus of Memorial Sloan-
Kettering Cancer Hospital, attributes the elusive nature
of cancer's cure to its inherently anarchic processes. In
1950, the discovery of cancer was all but a death
sentence. By 1980, 214 of every 100,000 Americans died
from cancer. As late as 1986, an article in the New
England Journal of Medicine revealed the less-than-
optimistic outlook cancer research, publishing the
condemning sentence: "We are losing the war against
cancer." In fact, though cancer had not been eliminated,
it had begun to be identified for what it is. A highly
individualistic disease, variable-a guerrilla cell rather
than a marching army. Suddenly science learned how to
fight the right war-at ever closer quarters. And at the
forefront of the momentous chain of discoveries was Paul
Marks. Chronicling the insights of researchers and doctors
around the world and the momentous effects of their pains-
taking advances- Marks weaves together the humbling
account of how and what we learned about the mechanisms of
malignant and abnormal cells that make up every one of us"
--Provided by publisher.
598 AVONNFIC
600 10 Marks, Paul A.
600 12 Marks, Paul A.
650 0 Cancer|xResearch.
650 0 Cancer|xTreatment|xResearch.
650 0 Tumors|xTreatment|xResearch.
650 0 Medicine|xResearch.
650 12 Neoplasms|xhistory.
650 22 Antineoplastic Agents|xhistory.
650 22 Biomedical Research.
650 22 Cell Transformation, Neoplastic.
650 22 Medical Oncology|xhistory.
650 22 Neoplasms|xtherapy.
700 1 Sterngold, James,|eauthor.
994 92|bCKE